Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability-Reference-Cited by-同舟云学术

Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability

Published:2022-12 Issue: Volume: Page:
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Levinstein Marjorie R.^ORCID,Carlton Meghan L.,Di Ianni Tommaso,Ventriglia Emilya N.,Rizzo Arianna,Gomez Juan L.,Budinich Reece C.,Shaham Yavin,Airan Raag D.,Zarate Carlos A.,Bonaventura Jordi^ORCID,Michaelides Michael^ORCID

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference51 articles.

1. Esketamine for treatment-resistant depression - First FDA-approved antidepressant in a new class;Kim;N Engl J Med,2019

2. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression;aan het Rot;Biol Psychiatry,2010

3. Principles of laboratory assessment of drug abuse liability and implications for clinical development;Carter;Drug Alcohol Depend,2009

4. Pharmacological and behavioral divergence of ketamine enantiomers: Implications for abuse liability;Bonaventura;Mol Psychiatry,2021

5. R-ketamine: A rapid-onset and sustained antidepressant without psychotomimetic side effects [published correction appears in Transl Psychiatry 2020;10:295];Yang;Transl Psychiatry,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model;Neuropharmacology;2024-10

2. Endogenous opiates and behavior: 2023;Peptides;2024-09

3. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS);Journal of Affective Disorders;2024-09

4. Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions;Journal of Anesthesia and Translational Medicine;2024-09

5. Ketamine and Esketamine for Depression in Daily Practice;Journal of Clinical Psychopharmacology;2024-08-22